Recent SGMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2024 08:06:44 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2024 08:05:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 12:06:14 PM
- Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 03/25/2024 10:15:00 AM
- Sagimet Biosciences to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 02/29/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 11:10:36 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:37:44 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/05/2024 09:34:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:36:16 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:05:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:56:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:55:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:05:22 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/26/2024 05:15:07 AM
- Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock • GlobeNewswire Inc. • 01/26/2024 01:58:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 11:10:07 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/24/2024 11:08:07 AM
- Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock • GlobeNewswire Inc. • 01/23/2024 10:45:51 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/23/2024 10:31:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:00:39 PM
- Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH • GlobeNewswire Inc. • 01/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:16:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:05:24 PM
- Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic • GlobeNewswire Inc. • 12/04/2023 01:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM